http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-169499-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B43-04 |
filingDate | 1997-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d2a29f1e9914aef7262f20589205d26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c8d5b9e23a7faa8503a0f1a9a46b43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdd3a44a38e59fa9068ef4463de28df |
publicationDate | 2000-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CZ-169499-A3 |
titleOfInvention | Methods for producing substituted pyridines |
abstract | The invention relates to processes for the preparation of the compound of formula (I),nwhich are β-adrenergic receptor agonists. Next, the solutionnrelates to methods for producing certain intermediates of formulanIIA wherein R 1 is nitro, amino orna protected amino group; R 2 represents hydrogen, fluoro, CF 3,nNitro, (C 1 -C 4) alkyl,n? (C 1 -C 4) alkoxy, amino orn4 protected amino group; and X 1 is hydroxynor a suitable leaving group. These intermediates arenuses βadrenergic agonists in the above methodsnreceptor. The invention also relates to compoundsnof Formula F1. |
priorityDate | 1997-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 331.